Bayer Ups Guidance While Pharma Head Highlights NHL Drug Copanlisib

 
• By Lucie Ellis-Taitt
  
Cancer cell
Bayer's pharma head zooms in on regulatory progress for NHL drug in 1Q earnings call

More from Strategy

More from Business